Medical device licence · 80430 · Class 3
VISCOELASTIC INJECTABLE GEL
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed August 10, 2009; ended September 22, 2020. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 80430
- Licence holder
- Anteis S.A.Plan-Les-Ouates, Geneva, Switzerland
- Risk class
- Class III (moderate to high risk)
- Licence type
- Device Family
- First licensed
- August 10, 2009
- Ended
- September 22, 2020
- Devices covered
- 7
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- BELOTERO HYDRO
- MESOLIS + LIDOCAINE
- MESOLIS VISCOELASTIC INJ GEL FOR DERMAL TISSUE REHYD W/NON-ANIMAL SO4 HYAL
- MESOLIS+
- MESOLIS+ + LIDOCAINE
- MESOLIS+ FOR THE ANTEIS INJECTION SYSTEM
- MESOLIS+ VISCOELASTIC INJ GEL-DERM TISSUE REHYD W/NON-ANIMAL SO4 HYAL & GLY
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.